Erratum: Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools (PLoS Genet (2016) 12:1 (e1005756) DOI: 10.1371/journal.pgen.1005756);Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools

PLoS Genetics

Volumn 12, Issue 1, 2016, Pages

  Soukarieh, Omar ^a   Gaildrat, Pascaline ^a   Hamieh, Mohamad ^a,c   Drouet, Aurélie ^a   Baert Desurmont, Stéphanie ^a,b   Frébourg, Thierry ^a,b   Tosi, Mario ^a   Martins, Alexandra ^a  

^a UNIVERSITY OF ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN MLH1; BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN; CFTR PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; MUTL PROTEIN HOMOLOG 1; NEUROFIBROMIN; NUCLEAR PROTEIN; RNA SPLICE SITE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; BIOINFORMATICS; CFTR GENE; COMPUTER MODEL; CONTROLLED STUDY; EXON; EXONIC SPLICING REGULATORY ELEMENT; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MLH1 GENE; NF1 GENE; PREDICTION; REGULATORY SEQUENCE; RNA SPLICING; TUMOR SUPPRESSOR GENE; COMPUTER SIMULATION; FEMALE; GENETICS; OVARY TUMOR; PATHOLOGY; RNA SPLICE SITE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BRCA1 PROTEIN; BRCA2 PROTEIN; COMPUTER SIMULATION; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; FEMALE; HUMANS; MUTL PROTEIN HOMOLOG 1; NEUROFIBROMIN 1; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; RNA SPLICE SITES; RNA SPLICING;

EID: 84958729894     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/JOURNAL.PGEN.1005971     Document Type: Erratum

References (43)

1. Rabbani B, Tekin M, Mahdieh N, The promise of whole-exome sequencing in medical genetics. J Hum Genet. 2014;59: 5–15. doi: 10.1038/jhg.2013.114 24196381
2. Frebourg T, The challenge for the next generation of medical geneticists. Hum Mutat. 2014;35: 909–911. doi: 10.1002/humu.22592 24838402
3. Wu J, Li Y, Jiang R, Integrating multiple genomic data to predict disease-causing nonsynonymous single nucleotide variants in exome sequencing studies. PLoS Genet. 2014;10: e1004237. doi: 10.1371/journal.pgen.1004237 24651380
4. Pabinger S, Dander A, Fischer M, Snajder R, Sperk M, Efremova M, et al. A survey of tools for variant analysis of next-generation genome sequencing data. Brief Bioinform. 2014;15: 256–278. doi: 10.1093/bib/bbs086 23341494
5. Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S, et al. A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet. 2014;86: 229–237. doi: 10.1111/cge.12315 24304220
6. Kichaev G, Yang W-Y, Lindstrom S, Hormozdiari F, Eskin E, Price AL, et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 2014;10: e1004722. doi: 10.1371/journal.pgen.1004722 25357204
7. González-Pérez A, López-Bigas N, Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011;88: 440–449. doi: 10.1016/j.ajhg.2011.03.004 21457909
8. Cline MS, Karchin R, Using bioinformatics to predict the functional impact of SNVs. Bioinforma Oxf Engl. 2011;27: 441–448.
9. Frousios K, Iliopoulos CS, Schlitt T, Simpson MA, Predicting the functional consequences of non-synonymous DNA sequence variants—evaluation of bioinformatics tools and development of a consensus strategy. Genomics. 2013;102: 223–228. doi: 10.1016/j.ygeno.2013.06.005 23831115
10. Cartegni L, Chew SL, Krainer AR, Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3: 285–298. 11967553
11. Sterne-Weiler T, Howard J, Mort M, Cooper DN, Sanford JR, Loss of exon identity is a common mechanism of human inherited disease. Genome Res. 2011;21: 1563–1571. doi: 10.1101/gr.118638.110 21750108
12. Spurdle AB, Couch FJ, Hogervorst FBL, Radice P, Sinilnikova OM, Prediction and Assessment of Splicing Alterations: Implications for clinical testing. Hum Mutat. 2008;29: 1304–1313. doi: 10.1002/humu.20901 18951448
13. Tournier I, Vezain M, Martins A, Charbonnier F, Baert-Desurmont S, Olschwang S, et al. A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Hum Mutat. 2008;29: 1412–1424. doi: 10.1002/humu.20796 18561205
14. Théry JC, Krieger S, Gaildrat P, Révillion F, Buisine M-P, Killian A, et al. Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet EJHG. 2011;19: 1052–1058. doi: 10.1038/ejhg.2011.100 21673748
15. Houdayer C, Caux-Moncoutier V, Krieger S, Barrois M, Bonnet F, Bourdon V, et al. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat. 2012;33: 1228–1238. doi: 10.1002/humu.22101 22505045
16. Ke S, Shang S, Kalachikov SM, Morozova I, Yu L, Russo JJ, et al. Quantitative evaluation of all hexamers as exonic splicing elements. Genome Res. 2011;21: 1360–1374. doi: 10.1101/gr.119628.110 21659425
17. Di Giacomo D, Gaildrat P, Abuli A, Abdat J, Frébourg T, Tosi M, et al. Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements. Hum Mutat. 2013;34: 1547–1557. doi: 10.1002/humu.22428 23983145
18. Erkelenz S, Theiss S, Otte M, Widera M, Peter JO, Schaal H, Genomic HEXploring allows landscaping of novel potential splicing regulatory elements. Nucleic Acids Res. 2014;42: 10681–10697. doi: 10.1093/nar/gku736 25147205
19. Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RKC, et al. The human splicing code reveals new insights into the genetic determinants of disease. Science. 2014;
20. Baralle D, Lucassen A, Buratti E, Missed threads. The impact of pre-mRNA splicing defects on clinical practice. EMBO Rep. 2009;10: 810–816. doi: 10.1038/embor.2009.170 19648957
21. Lim KH, Ferraris L, Filloux ME, Raphael BJ, Fairbrother WG, Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc Natl Acad Sci U S A. 2011;108: 11093–11098. doi: 10.1073/pnas.1101135108 21685335
22. Grandval P, Fabre AJ, Gaildrat P, Baert-Desurmont S, Buisine M-P, Ferrari A, et al. UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families. Database J Biol Databases Curation. 2013;2013: bat036.
23. Thompson BA, Spurdle AB, Plazzer J-P, Greenblatt MS, Akagi K, Al-Mulla F, et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet. 2014;46: 107–115. doi: 10.1038/ng.2854 24362816
24. Lastella P, Surdo NC, Resta N, Guanti G, Stella A, In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics. 2006;7: 243. 16995940
25. Charbonnier F, Martin C, Scotte M, Sibert L, Moreau V, Frebourg T, Alternative splicing of MLH1 messenger RNA in human normal cells. Cancer Res. 1995;55: 1839–1841. 7728749
26. Genuardi M, Viel A, Bonora D, Capozzi E, Bellacosa A, Leonardi F, et al. Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. Hum Genet. 1998;102: 15–20. 9490293
27. Thompson BA, Martins A, Spurdle AB, A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays. Clin Genet. 2014.
28. Vezain M, Saugier-Veber P, Goina E, Touraine R, Manel V, Toutain A, et al. A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy. Hum Mutat. 2010;31: E1110–1125. doi: 10.1002/humu.21173 19953646
29. Raponi M, Kralovicova J, Copson E, Divina P, Eccles D, Johnson P, et al. Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Hum Mutat. 2011;32: 436–444. doi: 10.1002/humu.21458 21309043
30. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR, ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31: 3568–3571. 12824367
31. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR, An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet. 2006;15: 2490–2508. 16825284
32. Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C, Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37: e67. doi: 10.1093/nar/gkp215 19339519
33. Pagani F, Stuani C, Tzetis M, Kanavakis E, Efthymiadou A, Doudounakis S, et al. New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum Mol Genet. 2003;12: 1111–1120. 12719375
34. Pagani F, Raponi M, Baralle FE, Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci U S A. 2005;102: 6368–6372. 15840711
35. Baralle M, Skoko N, Knezevich A, De Conti L, Motti D, Bhuvanagiri M, et al. NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region. FEBS Lett. 2006;580: 4449–4456. 16870183
36. Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, Desseigne F, et al. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat. 2006;27: 145–154. 16395668
37. Gaildrat P, Krieger S, Di Giacomo D, Abdat J, Révillion F, Caputo S, et al. Multiple sequence variants of BRCA2 exon 7 alter splicing regulation. J Med Genet. 2012;49: 609–617. doi: 10.1136/jmedgenet-2012-100965 22962691
38. Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet. 2009;85: 408–413. doi: 10.1016/j.ajhg.2009.08.002 19716110
39. Liu F, Gong C-X, Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener. 2008;3: 8. doi: 10.1186/1750-1326-3-8 18616804
40. Plotz G, Raedle J, Brieger A, Trojan J, Zeuzem S, N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha. Nucleic Acids Res. 2003;31: 3217–3226. 12799449
41. Buckler AJ, Chang DD, Graw SL, Brook JD, Haber DA, Sharp PA, et al. Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proc Natl Acad Sci U S A. 1991;88: 4005–4009. 1850845
42. Gaildrat P, Killian A, Martins A, Tournier I, Frébourg T, Tosi M, Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. Methods Mol Biol Clifton NJ. 2010;653: 249–257.
43. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR, Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989;77: 51–59. 2744487